| Carl Robinson, MD | |
|
3600 Prytania St, Ste 100, New Orleans, LA 70115-3600 | |
| (504) 899-5434 | |
| (504) 899-8668 |
| Full Name | Carl Robinson |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3600 Prytania St, New Orleans, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053315556 | NPI | - | NPPES |
| 1127566 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 03356 (Louisiana) | Secondary |
| 208000000X | Pediatrics | L03356R (Louisiana) | Primary |
| 171100000X | Acupuncturist | 200010 (Louisiana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Carl Robinson, MD 298 Henry Clay Ave, New Orleans, LA 70118-5720 Ph: (504) 896-9827 | Carl Robinson, MD 3600 Prytania St, Ste 100, New Orleans, LA 70115-3600 Ph: (504) 899-5434 |
News Archive
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the third quarter ended September 30, 2009.
The increased mortality risk observed among patients with severe psychiatric illness, including schizophrenia, does not seem to be attributable to use of psychopharmacologic therapy, study findings indicate.
A study led by Johns Hopkins Medicine researchers suggests that awakening several times throughout the night is more detrimental to people's positive moods than getting the same shortened amount of sleep without interruption.
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company's New Drug Application (NDA) for Fampridine-SR on October 14, 2009.
› Verified 6 days ago
Dr. Walter Jordan Hoyt Jr., M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3900 Fax: 504-842-5647 | |
Dr. Michael David Weiland Jr., M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1319 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3900 Fax: 504-842-5848 | |
Dr. Brian Barkemeyer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9418 | |
Dr. James Robinson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-8886 | |
Dr. Brandace J Hider, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2820 Napoleon Ave Ste 950, New Orleans, LA 70115 Phone: 504-897-4242 | |
Dr. Lutifat Kashimawo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Rodolfo E Begue, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9583 |